1. FujitaT, KobayaskiS. The cells and hormones of the GEP endocrine system – the current of the studies. In: FujitaT(ed). Gastro‐Entero‐Pancreatic Endocrine System: A Cell‐Biological Approach. Tokyo: Igaku Shoin; 1973: 1.

2. PolakJM. Endocrine cells of the gut. In: MakhloufGM(ed). Handbook of Physiology – The Gastrointestinal System. New York: Oxford University Press; 1989.

3. FrancoR, CanalsM, MarcellinoD, et al.Regulation of heptaspanning‐membrane‐receptor function by dimerization and clustering. Trends Biochem Sci2003;28:238. CrossRef

4. LangmeadCJ, ChristopoulosA. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox. Trends Pharmacol Sci2006;27:475. CrossRef

5. AngersS, SalahpourA, BouvierM. Dimerization: an emerging concept for G protein‐coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol2002;42:409. CrossRef

6. GoresGJ, LaRussoNF, MillerLJ. Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. Am J Physiol1986;250:G344.

7. MurakamiT, HitomiS, OhtsukaA, et al.Pancreatic insulo‐acinar portal systems in humans, rats, and some other mammals: scanning electron microscopy of vascular casts. Microsc Res Tech1997;37:478. CrossRef

8. SchmidA, SchulzI. Different time courses of GTP[gamma‐S]‐induced exocytosis and current oscillations in isolated mouse pancreatic acinar cells. Pflugers Arch1996;432:876. CrossRef

9. FurnessJB. Types of neurons in the enteric nervous system. J Auton Nerv Syst2000;81:87. CrossRef

10. LarssonLI, GoltermannN, de MagistrisL, et al.Somatostatin cell processes as pathways for paracrine secretion. Science1979;205:1393. CrossRef

11. RoettgerBF, RentschRU, PinonD, et al.Dual pathways of internalization of the cholecystokinin receptor. J Cell Biol1995;128:1029. CrossRef

12. RoettgerBF, RentschRU, HadacEM, et al.Insulation of a G protein‐coupled receptor on the plasmalemmal surface of the pancreatic acinar cell. J Cell Biol1995;130:579. CrossRef

13. RaoRV, RoettgerBF, HadacEM, et al.Roles of cholecystokinin receptor phosphorylation in agonist‐stimulated desensitization of pancreatic acinar cells and receptor‐bearing Chinese hamster ovary cholecystokinin receptor cells. Mol Pharmacol1997;51:185.

14. KenakinT. Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther2011;336:296. CrossRef

15. KenakinT, ChristopoulosA. Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat Rev Drug Discov2013;12:205. CrossRef

16. BaylissWM, StarlingEH. On the causation of the so‐called “peripheral reflex secretion” of the pancreas. Proc R Soc Lond [Biol]1902;69:352.

17. RehfeldJF. Historical background. In: BloomSR, PolakJM(eds). Gut Hormones. New York: Churchill Livingstone; 1981: 10.

18. EdkinsJS. On the chmical mechanisms of gastric secretion. Proc R Soc Lond [Biol]1905;76:376. CrossRef

19. GregoryRA, TracyHJ. The constitution and properties of two gastrins extracted from hog antral mucosa. Gut1964;5:103. CrossRef

20. MuttV, JorpesE. Hormonal polypeptides of the upper intestine. Biochem J1971;125:57P. CrossRef

21. YalowRS. Radioimmunoassay: a probe for the fine structure of biologic systems. Med Phys1978;5:247. CrossRef

22. YalowRS, BersonSA. Assay of plasma insulin in human subjects by immunological methods. Nature1959;184(Suppl 21):1648. CrossRef

23. MullerJE, StrausE, YalowRS. Cholecystokinin and its COOH‐terminal octapeptide in the pig brain. Proc Natl Acad Sci U S A1977;74:3035. CrossRef

24. MillerLJ. A historical perspective of gastrointestinal endocrinology–the new age of molecular receptorology. Gastroenterology1992;102:2168.

25. GalardyRE, CraigLC, JamiesonJD, et al.Photoaffinity labeling of peptide hormone binding sites. J Biol Chem1974;249:3510.

26. GalardyRE, HullBE, JamiesonJD. Irreversible photoactivation of a pancreatic secretagogue receptor with cholecystokinin COOH‐terminal octapeptides. J Biol Chem1980;255:3148.

27. DongM, LiuG, PinonDI, et al.Differential docking of high‐affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling. Biochemistry2005;44:6693. CrossRef

28. KolakowskiLFJr. GCRDb: a G‐protein‐coupled receptor database. Receptors Channels1994;2:1.

29. HoughtenRA, PinillaC, BlondelleSE, et al.Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature1991;354:84. CrossRef

30. AquinoCJ, ArmourDR, BermanJM, et al.Discovery of 1,5‐benzodiazepines with peripheral cholecystokinin (CCK‐A) receptor agonist activity. 1. Optimization of the agonist “trigger”. J Med Chem1996;39:562. CrossRef

31. ChengH, LeblondCP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat1974;141:537. CrossRef

32. ThompsonM, FlemingKA, EvansDJ, et al.Gastric endocrine cells share a clonal origin with other gut cell lineages. Development1990;110:477.

33. WangJ, CortinaG, WuSV, et al.Mutant neurogenin‐3 in congenital malabsorptive diarrhea. N Engl J Med2006;355:270. CrossRef

34. Le DouarinNM, DupinE, ZillerC. Genetic and epigenetic control in neural crest development. Curr Opin Genet Dev1994;4:685. CrossRef

35. Le DouarinNM, ZillerC. Plasticity in neural crest cell differentiation. Curr Opin Cell Biol1993;5:1036. CrossRef

36. JamiesonJD, PaladeGE. Synthesis, intracellular transport, and discharge of secretory proteins in stimulated pancreatic exocrine cells. J Cell Biol1971;50:135. CrossRef

37. PardueML, GallJG. Nucleic acid hybridization to the DNA of cytological preparations. Methods Cell Biol1975;10:1. CrossRef

38. SingerRH, LawrenceJB, VillnaveC. Optimization of in situ hybridization using isotopic and nonisotopic methods. BioTechniques1986;4:230.

39. NakanishiS, InoueA, KitaT, et al.Nucleotide sequence of cloned cDNA for bovine corticotropin‐beta‐lipotropin precursor. Nature1979;278:423. CrossRef

40. GublerU, SeeburgP, HoffmanBJ, et al.Molecular cloning establishes proenkephalin as precursor of enkephalin‐containing peptides. Nature1982;295:206. CrossRef

41. ItohN, ObataK, YanaiharaN, et al.Human preprovasoactive intestinal polypeptide contains a novel PHI‐27‐like peptide, PHM‐27. Nature1983;304:547. CrossRef

42. RosenfeldMG, MermodJJ, AmaraSG, et al.Production of a novel neuropeptide encoded by the calcitonin gene via tissue‐specific RNA processing. Nature1983;304:129. CrossRef

43. NawaH, KotaniH, NakanishiS. Tissue‐specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature1984;312:729. CrossRef

44. SongI, BrownDR, WiltshireRN, et al.The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc Natl Acad Sci U S A1993;90:9085. CrossRef

45. MooreEE, KuestnerRE, StroopSD, et al.Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Mol Endocrinol1995;9:959.

46. WalterP, GilmoreR, BlobelG. Protein translocation across the endoplasmic reticulum. Cell1984;38:5. CrossRef

47. HuttnerWB. Tyrosine sulfation and the secretory pathway. Annu Rev Physiol1988;50:363. CrossRef

48. SteinerDF, SmeekensSP, OhagiS, et al.The new enzymology of precursor processing endoproteases. J Biol Chem1992;267:23435.

49. SmeekensSP, AvruchAS, LaMendolaJ, et al.Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans. Proc Natl Acad Sci U S A1991;88:340. CrossRef

50. SeidahNG, MarcinkiewiczM, BenjannetS, et al.Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, Furin, and Kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. Mol Endocrinol1991;5:111. CrossRef

51. BradburyAF, FinnieMD, SmythDG. Mechanism of C‐terminal amide formation by pituitary enzymes. Nature1982;298:686. CrossRef

52. DickinsonCJ, YamadaT. Gastrin‐amidating enzyme in the porcine pituitary and antrum. Characterization of molecular forms and substrate specificity. J Biol Chem1991;266:334.

53. TatemotoK, MuttV. Chemical determination of polypeptide hormones. Proc Natl Acad Sci U S A1978;75:4115. CrossRef

54. VarroA, DockrayGJ. Post‐translational processing of progastrin: inhibition of cleavage, phosphorylation and sulphation by brefeldin A. Biochem J1993;295:813. CrossRef

55. GregoryH, JonesDS, MorleyHS. Polypeptides. VII. Variations of the phenylalanyl position in the C‐terminal tetrapeptide amide sequence of the gastrins. J Chem Soc [Perkin 1]1968;5:531.

56. MorleyJS. Structure–function relationships in gastrin‐like peptides. Proc R Soc Lond B Biol Sci1968;170:97. CrossRef

57. YooOJ, PowellCT, AgarwalKL. Molecular cloning and nucleotide sequence of full‐length of cDNA coding for porcine gastrin. Proc Natl Acad Sci U S A1982;79:1049. CrossRef

58. ItoR, SatoK, HelmerT, et al.Structural analysis of the gene encoding human gastrin: the large intron contains an Alu sequence. Proc Natl Acad Sci U S A1984;81:4662. CrossRef

59. WiborgO, BerglundL, BoelE, et al.Structure of a human gastrin gene. Proc Natl Acad Sci U S A1984;81:1067. CrossRef

60. VarroA, NemethJ, BridsonJ, et al.Processing of the gastrin precursor. Modulation of phosphorylated, sulfated, and amidated products. J Biol Chem1990;265:21476.

61. DockrayGJ. Physiology of enteric neuropeptides. In: JohnsonL(ed). Physiology of the Gastrointestinal Tract. New York: Raven Press; 1987: 41.

62. BundgaardJR, VuustJ, RehfeldJF. Tyrosine O‐sulfation promotes proteolytic processing of progastrin. EMBO J1995;14:3073.

63. OndettiMA, RubinB, EngelSL, et al.Cholecystokinin‐pancreozymin: recent developments. Am J Dig Dis1970;15:149. CrossRef

64. NikiforovichGV, HrubyVJ. Models for the A‐ and B‐receptor‐bound conformations of CCK‐8. Biochem Biophys Res Commun1993;194:9. CrossRef

65. MerrifieldRB. Solid‐phase peptide synthesis. Adv Enzymol Relat Areas Mol Biol1969;32:221.

66. RehfeldJF. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas. Scand J Gastroenterol Suppl1979;53:33.

67. OwyangC, MillerLJ, DiMagnoEP, et al.Gastrointestinal hormone profile in renal insufficiency. Mayo Clin Proc1979;54:769.

68. LamersCB, Von TongerrenJH. Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger‐Ellison syndrome. Gut1977;18:128. CrossRef

69. GrossmanMI. How does a candidate peptide become a hormone?Adv Exp Med Biol1978;106:23. CrossRef

70. BrownKD. The epidermal growth factor/transforming growth factor‐alpha family and their receptors. Eur J Gastroenterol Hepatol1995;7:914. CrossRef

71. SchmidC. Insulin‐like growth factors. Cell Biol Int1995;19:445. CrossRef

72. SlavinJ. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int1995;19:431. CrossRef

73. KoeslingD, BohmeE, SchultzG. Guanylyl cyclases, a growing family of signal‐transducing enzymes. FASEB J1991;5:2785.

74. LodishHF, HiltonDJ, KlingmullerU, et al.The erythropoietin receptor: biogenesis, dimerization, and intracellular signal transduction. Cold Spring Harb Symp Quant Biol1995;60:93. CrossRef

75. WatowichSS, WuH, SocolovskyM, et al.Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu Rev Cell Dev Biol1996;12:91. CrossRef

76. LuetjeCW, PatrickJ, SeguelaP. Nicotine receptors in the mammalian brain. FASEB J1990;4:2753.

77. DohlmanHG, CaronMG, LefkowitzRJ. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry1987;26:2657. CrossRef

78. JiTH, GrossmannM, JiI. G protein‐coupled receptors. I. Diversity of receptor‐ligand interactions. J Biol Chem1998;273:17299. CrossRef

79. GilmanAG. G proteins: transducers of receptor‐generated signals. Annu Rev Biochem1987;56:615. CrossRef

80. HeplerJR, GilmanAG. G proteins. Trends Biochem Sci1992;17:383. CrossRef

81. WhalenEJ, RajagopalS, LefkowitzRJ. Therapeutic potential of beta‐arrestin‐ and G protein‐biased agonists. Trends Mol Med2011;17:126. CrossRef

82. ConklinBR, BourneHR. Structural elements of G alpha subunits that interact with G beta gamma, receptors, and effectors. Cell1993;73:631. CrossRef

83. BirnbaumerL. G proteins in signal transduction. Annu Rev Pharmacol Toxicol1990;30:675. CrossRef

84. NeerEJ, ClaphamDE. Roles of G protein subunits in transmembrane signalling. Nature1988;333:129. CrossRef

85. FordCE, SkibaNP, BaeH, et al.Molecular basis for interactions of G protein betagamma subunits with effectors. Science1998;280:1271. CrossRef

86. O'DonnellM, GarippaRJ, O'NeillNC, et al.Structure‐activity studies of vasoactive intestinal polypeptide. J Biol Chem1991;266:6389.

87. FeighnerSD, TanCP, McKeeKK, et al.Receptor for motilin identified in the human gastrointestinal system. Science1999;284:2184. CrossRef

88. SpenglerD, WaeberC, PantaloniC, et al.Differential signal transduction by five splice variants of the PACAP receptor. Nature1993;365:170. CrossRef

89. HeleniusA, HowN. linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Mol Biol Cell1994;5:253. CrossRef

90. KaushalS, RidgeKD, KhoranaHG. Structure and function in rhodopsin: the role of asparagine‐linked glycosylation. Proc Natl Acad Sci U S A1994;91:4024. CrossRef

91. MoffettS, MouillacB, BoninH, et al.Altered phosphorylation and desensitization patterns of a human beta 2‐adrenergic receptor lacking the palmitoylated Cys341. EMBO J1993;12:349.

92. OzcelebiF, RaoRV, HolickyE, et al.Phosphorylation of cholecystokinin receptors expressed on Chinese hamster ovary cells. Similarities and differences relative to native pancreatic acinar cell receptors. J Biol Chem1996;271:3750. CrossRef

93. BenovicJL, DeBlasiA, StoneWC, et al.Beta‐adrenergic receptor kinase: primary structure delineates a multigene family. Science1989;246:235. CrossRef

94. RosenzweigSA, MillerLJ, JamiesonJD. Identification and localization of cholecystokinin‐binding sites on rat pancreatic plasma membranes and acinar cells: a biochemical and autoradiographic study. J Cell Biol1983;96:1288. CrossRef

95. MillerLJ. Biochemical characterization of receptors for the cholecystokinin family of hormones. In: ThompsonJC(ed). Gastrointestinal Endocrinology: Receptors and Post‐Receptor Mechanisms. New York: Academic Press; 1990: 81. CrossRef

96. GranierS, KobilkaB. A new era of GPCR structural and chemical biology. Nat Chem Biol2012;8:670. CrossRef

97. DongM, XuX, BallAM, et al.Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping. FASEB J2012;26:5092. CrossRef

98. JohnsenAH, RehfeldJF. Identification of cholecystokinin/gastrin peptides in frog and turtle. Evidence that cholecystokinin is phylogenetically older than gastrin. Eur J Biochem1992;207:419. CrossRef

99. VignaSR. Cholecystokinin and its receptors in vertebrates and invertebrates. Peptides1985;6(Suppl 3):283. CrossRef

100. OliverAS, VignaSR. CCK‐A‐ and CCK‐B‐like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis). Gen Comp Endocrinol1997;105:91. CrossRef

101. DelValleJ, SuganoK, YamadaT. Glycine‐extended processing intermediates of gastrin and cholecystokinin in human plasma. Gastroenterology1989;97:1159.

102. LuttichauHR, Van SolingeWW, NielsenFC, et al.Developmental expression of the gastrin and cholecystokinin genes in rat colon. Gastroenterology1993;104:1092.

103. BrandSJ, FullerPJ. Differential gastrin gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem1988;263:5341.

104. Van SolingeWW, NielsenFC, Friis‐HansenL, et al.Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology1993;104:1099.

105. RehfeldJF, BardramL, HilstedL. Gastrin in human bronchogenic carcinomas: constant expression but variable processing of progastrin. Cancer Res1989;49:2840.

106. ZollingerRM, EllisonEH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg1955;142:709. CrossRef

107. WalshJH. Gastrointestinal hormones. In: JohnsonLR(ed). Physiology of the Gastrointestinal Tract. New York: Raven Press; 1987: 181.

108. WankSA. Cholecystokinin receptors. Am J Physiol1995;269:G628.

109. JensenRT, WankSA, RowleyWH, et al.Interaction of CCK with pancreatic acinar cells. Trends Pharmacol Sci1989;10:418. CrossRef

110. ChangRS, ChenTB, BockMG, et al.Characterization of the binding of [3H]L‐365,260: a new potent and selective brain cholecystokinin (CCK‐B) and gastrin receptor antagonist radioligand. Mol Pharmacol1989;35:803.

111. IversenLL, DourishCT, IversenSD. Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications. Biochem Soc Trans1991;19:913. CrossRef

112. SollAH, AmirianDA, ThomasLP, et al.Gastrin receptors on isolated canine parietal cells. J Clin Invest1984;73:1434. CrossRef

113. SollAH. The interaction of histamine with gastrin and carbamylcholine on oxygen uptake by isolated mammalian parietal cells. J Clin Invest1978;61:381. CrossRef

114. RybergB, TielemansY, AxelsonJ, et al.Gastrin stimulates the self‐replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin‐17 in intact and antrectomized rats. Gastroenterology1990;99:935.

115. WillemsG, VansteenkisteY, LimboschJM. Stimulating effect of gastrin on cell proliferation kinetics in canine fundic mucosa. Gastroenterology1972;62:583.

116. JianuCS, FossmarkR, VisetT, et al.Gastric carcinoids after long‐term use of a proton pump inhibitor. Aliment Pharmacol Ther2012;36:644. CrossRef

117. FossmarkR, SordalO, JianuCS, et al.Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Aliment Pharmacol Ther2012;36:1067. CrossRef

118. BlackJW. Reflections on some pilot trials of gastrin receptor blockade in pancreatic cancer. Eur J Cancer2009;45:360. CrossRef

119. NagataA, ItoM, IwataN, et al.G protein‐coupled cholecystokinin‐B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc Natl Acad Sci U S A1996;93:11825. CrossRef

120. DickinsonCJ. Relationship of gastrin processing to colon cancer. Gastroenterology1995;109:1384. CrossRef

121. DockrayGJ. Gastrin, growth, and colon neoplasia. Gut2000;47:747. CrossRef

122. WangTC, KohTJ, VarroA, et al.Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest1996;98:1918. CrossRef

123. EysseleinVE, ReeveJRJr, ShivelyJE, et al.Partial structure of a large canine cholecystokinin (CCK58): amino acid sequence. Peptides1982;3:687. CrossRef

124. CuberJC, BernardC, GibardT, et al.Pharmacokinetics and organ catabolism of cholecystokinin octapeptide in pigs. Regul Pept1989;26:203. CrossRef

125. GoresGJ, MillerLJ, LaRussoNF. Hepatic processing of cholecystokinin peptides. II. Cellular metabolism, transport, and biliary excretion. Am J Physiol1986;250:G350.

126. BuchanAM, PolakJM, SolciaE, et al.Electron immunohistochemical evidence for the human intestinal I cell as the source of CCK. Gut1978;19:403. CrossRef

127. LiddleRA, GoldfineID, WilliamsJA. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology1984;87:542.

128. RehfeldJF. How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid. Regul Pept1998;78:31. CrossRef

129. LiddleRA, GoldfineID, RosenMS, et al.Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest1985;75:1144. CrossRef

130. FolschUR, CantorP, WilmsHM, et al.Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology1987;92:449.

131. MiyasakaK, GuanDF, LiddleRA, et al.Feedback regulation by trypsin: evidence for intraluminal CCK‐releasing peptide. Am J Physiol1989;257:G175.

132. LuL, LouieD, OwyangC. A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion. Am J Physiol1989;256:G430.

133. KoopI, KoopH, GerhardtC, et al.Do bile acids exert a negative feedback control of cholecystokinin release?Scand J Gastroenterol1989;24:315. CrossRef

134. HerzigKH, SchonI, TatemotoK, et al.Diazepam binding inhibitor is a potent cholecystokinin‐releasing peptide in the intestine. Proc Natl Acad Sci U S A1996;93:7927. CrossRef

135. SpannagelAW, GreenGM, GuanD, et al.Purification and characterization of a luminal cholecystokinin‐releasing factor from rat intestinal secretion. Proc Natl Acad Sci U S A1996;93:4415. CrossRef

136. LerchMM, GorelickFS. Models of acute and chronic pancreatitis. Gastroenterology2013;144:1180. CrossRef

137. KopinAS, LeeYM, McBrideEW, et al.Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci U S A1992;89:3605. CrossRef

138. DongM, LamPC, PinonDI, et al.Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site‐specific intrinsic photoaffinity labeling and molecular modeling. Biochemistry2009;48:5303. CrossRef

139. EvansBE, BockMG, RittleKE, et al.Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proc Natl Acad Sci U S A1986;83:4918. CrossRef

140. PotterRM, HarikumarKG, WuSV, et al.Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol. J Lipid Res2012;53:137. CrossRef

141. LiddleRA. Cholecystokinin. In: WalshJH, DockrayGJ(eds). Gut Peptides: Biochemistry and Physiology. New York: Raven Press; 1994: 175.

142. MoranTH. Gut peptides in the control of food intake. Int J Obes (Lond)2009;33(Suppl 1):S7. CrossRef

143. StanleyS, WynneK, BloomS. Gastrointestinal satiety signals III. Glucagon‐like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am J Physiol Gastrointest Liver Physiol2004;286:G693. CrossRef

144. BerglundMM, HipskindPA, GehlertDR. Recent developments in our understanding of the physiological role of PP‐fold peptide receptor subtypes. Exp Biol Med (Maywood)2003;228:217.

145. GloverID, BarlowDJ, PittsJE, et al.Conformational studies on the pancreatic polypeptide hormone family. Eur J Biochem1984;142:379. CrossRef

146. BlundellTL, PittsJE, TickleIJ, et al.X‐ray analysis (1. 4‐A resolution) of avian pancreatic polypeptide: small globular protein hormone. Proc Natl Acad Sci U S A1981;78:4175. CrossRef

147. PhengLH, RegoliD. Receptors for NPY in peripheral tissues bioassays. Life Sci2000;67:847. CrossRef

148. FuhlendorffJ, GetherU, AakerlundL, et al.[Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist. Proc Natl Acad Sci U S A1990;87:182. CrossRef

149. TatemotoK, NakanoI, MakkG, et al.Isolation and primary structure of human peptide YY. Biochem Biophys Res Commun1988;157:713. CrossRef

150. TaylorIL. Distribution and release of peptide YY in dog measured by specific radioimmunoassay. Gastroenterology1985;88:731.

151. AdrianTE, FerriGL, Bacarese‐HamiltonAJ, et al.Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology1985;89:1070.

152. PappasTN, DebasHT, ChangAM, et al.Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs. Gastroenterology1986;91:1386.

153. PappasTN, DebasHT, TaylorIL. Peptide YY: metabolism and effect on pancreatic secretion in dogs. Gastroenterology1985;89:1387.

154. TatemotoK, SiimesmaaS, JornvallH, et al.Isolation and characterization of neuropeptide Y from porcine intestine. FEBS Lett1985;179:181. CrossRef

155. TatemotoK. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A1982;79:5485. CrossRef

156. FurnessJB, CostaM, EmsonPC, et al.Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y‐ and pancreatic polypeptide‐like immunoreactivity in the guinea‐pig digestive tract. Cell Tissue Res1983;234:71. CrossRef

157. KochTR, RoddyDR, CarneyJA, et al.Distribution, quantitation, and origin of immunoreactive neuropeptide Y in the human gastrointestinal tract. Regul Pept1988;21:309. CrossRef

158. CrowleyWR, ShahGV, CarrollBL, et al.Neuropeptide‐Y enhances luteinizing hormone (LH)‐releasing hormone‐induced LH release and elevations in cytosolic Ca2+ in rat anterior pituitary cells: evidence for involvement of extracellular Ca2+ influx through voltage‐sensitive channels. Endocrinology1990;127:1487. CrossRef

159. LundbergJM, TorssellL, SolleviA, et al.Neuropeptide Y and sympathetic vascular control in man. Regul Pept1985;13:41. CrossRef

160. PalmaC. Tachykinins and their receptors in human malignancies. Curr Drug Targets2006;7:1043. CrossRef

161. ImprotaG, BroccardoM. Tachykinins: role in human gastrointestinal tract physiology and pathology. Curr Drug Targets2006;7:1021. CrossRef

162. SatakeH, KawadaT. Overview of the primary structure, tissue‐distribution, and functions of tachykinins and their receptors. Curr Drug Targets2006;7:963. CrossRef

163. EstebanF, MunozM, Gonzalez‐MolesMA, et al.A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev2006;25:137. CrossRef

164. ChangMM, LeemanSE, NiallHD. Amino‐acid sequence of substance P. Nat New Biol1971;232:86. CrossRef

165. ErspamerV. Discovery, isolation, and characterization of bombesin‐like peptides. Ann N Y Acad Sci1988;547:3. CrossRef

166. Lebacq‐VerheydenAM, TrepelJ, SausvilleEA, et al.Bombesin and gastrin‐releasing peptide: neuropeptides, secretagogues, and growth factors. In: SpornMB, RobertsAB(eds). Peptide Growth Factors and their Receptors. Heidelberg: Springer‐Verlag; 1991: 71.

167. JianX, SainzE, ClarkWA, et al.The bombesin receptor subtypes have distinct G protein specificities. J Biol Chem1999;274:11573. CrossRef

168. KatsunoT, PradhanTK, RyanRR, et al.Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4‐R). Biochemistry1999;38:7307. CrossRef

169. GoodmanRH, JacobsJW, ChinWW, et al.Nucleotide sequence of a cloned structural gene coding for a precursor of pancreatic somatostatin. Proc Natl Acad Sci U S A1980;77:5869. CrossRef

170. van der LelyAJ, KopchickJJ. Growth hormone receptor antagonists. Neuroendocrinology2006;83:264. CrossRef

171. SgourosSN, BergeleC, ViazisN, et al.Somatostatin and its analogues in peptic ulcer bleeding: facts and pathophysiological aspects. Dig Liver Dis2006;38:143. CrossRef

172. de HerderWW, KwekkeboomDJ, ValkemaR, et al.Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Invest2005;28:132.

173. TrentDF, WeirGC. Heterogeneity of somatostatin‐like peptides in rat brain, pancreas, and gastrointestinal tract. Endocrinology1981;108:2033. CrossRef

174. VinikAI, GaginellaTS, O'DorisioTM, et al.The distribution and characterization of somatostatin‐like immunoreactivity in epithelial cells, submucosa, and muscle of the rat stomach and intestine. Endocrinology1981;109:1921. CrossRef

175. YamadaY, PostSR, WangK, et al.Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A1992;89:251. CrossRef

176. ReisineT. Somatostatin receptors. Am J Physiol1995;269:G813.

177. BenaliN, FerjouxG, PuenteE, et al.Somatostatin receptors. Digestion2000;62:27. CrossRef

178. RuskoneA, ReneE, ChayvialleJA, et al.Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci1982;27:459. CrossRef

179. PeetersTL, DepoortereI. Motilin receptor: a model for development of prokinetics. Dig Dis Sci1994;39:76S. CrossRef

180. PeetersTL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology1993;105:1886.

181. MatsuuraB, DongM, NaikS, et al.Differential contributions of motilin receptor extracellular domains for peptide and non‐peptidyl agonist binding and activity. J Biol Chem2006;281:12390. CrossRef

182. MatsuuraB, DongM, CoulieB, et al.Demonstration of a specific site of covalent labeling of the human motilin receptor using a biologically active photolabile motilin analog. J Pharmacol Exp Ther2005;313:1101. CrossRef

183. KojimaM, HosodaH, DateY, et al.Ghrelin is a growth‐hormone‐releasing acylated peptide from stomach. Nature1999;402:656. CrossRef

184. PoitrasP, MillerP, DicknerM, et al.Heterogeneity of motilin receptors in the gastrointestinal tract of the rabbit. Peptides1996;17:701. CrossRef

185. HollenbergMD, SaifeddineM, al‐AniB. Proteinase‐activated receptor‐2 in rat aorta: structural requirements for agonist activity of receptor‐activating peptides. Mol Pharmacol1996;49:229.

186. HollenbergMD. Protease‐mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol Sci1996;17:3. CrossRef

187. SchmidtVA, VitaleE, BahouWF. Genomic cloning and characterization of the human thrombin receptor gene. Structural similarity to the proteinase activated receptor‐2 gene. J Biol Chem1996;271:9307. CrossRef

188. NystedtS, EmilssonK, LarssonAK, et al.Molecular cloning and functional expression of the gene encoding the human proteinase‐activated receptor 2. Eur J Biochem1995;232:84. CrossRef

189. DefeaK, SchmidlinF, DeryO, et al.Mechanisms of initiation and termination of signalling by neuropeptide receptors: a comparison with the proteinase‐activated receptors. Biochem Soc Trans2000;28:419. CrossRef

190. TettamantiG, MalagoliD, BenelliR, et al.Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates. Curr Med Chem2006;13:2737. CrossRef

191. GilesR, LobergRD. Can we target the chemokine network for cancer therapeutics?Curr Cancer Drug Targets2006;6:659. CrossRef

192. ViolaA, ContentoRL, MolonB. T cells and their partners: the chemokine dating agency. Trends Immunol2006;27:421. CrossRef

193. MurphyPM, BaggioliniM, CharoIF, et al.International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev2000;52:145.

194. IshiharaT, NakamuraS, KaziroY, et al.Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J1991;10:1635.

195. IshiharaT, ShigemotoR, MoriK, et al.Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron1992;8:811. CrossRef

196. UsdinTB, MezeyE, ButtonDC, et al.Gastric inhibitory polypeptide receptor, a member of the secretin‐vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology1993;133:2861.

197. JuppnerH, Abou‐SamraAB, FreemanM, et al.A G protein‐linked receptor for parathyroid hormone and parathyroid hormone‐related peptide. Science1991;254:1024. CrossRef

198. UlrichCD2nd, HoltmannM, MillerLJ. Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein‐coupled receptors. Gastroenterology1998;114:382. CrossRef

199. DongM, MillerLJ. Molecular pharmacology of the secretin receptor. Receptors Channels2002;8:189. CrossRef

200. CarlquistM. Human secretin is not identical to the porcine/bovine hormone. IRCS Med Sci1985;13:217.

201. WelchMG. Review: secretin is not effective for the treatment of children with autism spectrum disorders. Evid Based Ment Health2011;14:104. CrossRef

202. LisenbeeCS, DongM, MillerLJ. Paired cysteine mutagenesis to establish the pattern of disulfide bonds in the functional intact secretin receptor. J Biol Chem2005;280:12330. CrossRef

203. DohlmanHG, CaronMG, DeBlasiA, et al.Role of extracellular disulfide‐bonded cysteines in the ligand binding function of the beta 2‐adrenergic receptor. Biochemistry1990;29:2335. CrossRef

204. ParthierC, Reedtz‐RungeS, RudolphR, et al.Passing the baton in class B GPCRs: peptide hormone activation via helix induction?Trends Biochem Sci2009;34:303. CrossRef

205. MillerLJ, DongM, HarikumarKG. Ligand binding and activation of the secretin receptor, a prototypic family B G protein‐coupled receptor. Br J Pharmacol2012;166:18. CrossRef

206. HoltmannMH, RoettgerBF, PinonDI, et al.Role of receptor phosphorylation in desensitization and internalization of the secretin receptor. J Biol Chem1996;271:23566. CrossRef

207. MurphyKG, BloomSR. Nonpeptidic glucagon‐like peptide 1 receptor agonists: a magic bullet for diabetes?Proc Natl Acad Sci U S A2007;104:689. CrossRef

208. EngJ, KleinmanWA, SinghL, et al.Isolation and characterization of exendin‐4, an exendin‐3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem1992;267:7402.

209. WillardFS, BuenoAB, SloopKW. Small molecule drug discovery at the glucagon‐like peptide‐1 receptor. Exp Diabesity Res2012;2012:709893.

210. SinghS, ChangHY, RichardsTM, et al.Glucagon‐like peptide 1‐based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population‐based matched case‐control study. JAMA Intern Med2013;173:534. CrossRef

211. ButlerPC, ElashoffM, ElashoffR, et al.A critical analysis of the clinical use of incretin‐based therapies: are the GLP‐1 therapies safe?Diabetes Care2013;36:2118. CrossRef

212. NauckMA. A Critical Analysis of the Clinical Use of Incretin‐Based Therapies: the benefits by far outweigh the potential risks. Diabetes Care2013;36:2126. CrossRef

213. AdelhorstK, HedegaardBB, KnudsenLB, et al.Structure‐activity studies of glucagon‐like peptide‐1. J Biol Chem1994;269:6275.

214. MortensenK, ChristensenLL, HolstJJ, et al.GLP‐1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept2003;114:189. CrossRef

215. DonnellyD. The structure and function of the glucagon‐like peptide‐1 receptor and its ligands. Br J Pharmacol2012;166:27. CrossRef

216. MuttV, SaidSI. Structure of the porcine vasoactive intestinal octacosapeptide. The amino‐acid sequence. Use of kallikrein in its determination. Eur J Biochem1974;42:581. CrossRef

217. WaschekJA. VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. Br J Pharmacol2013;169:512. CrossRef

218. BloomSR. Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: value of measurement in diagnosis and treatment. Am J Dig Dis1978;23:373. CrossRef

219. UsdinTB, BonnerTI, MezeyE. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology1994;135:2662.

220. PisegnaJR, WankSA. Molecular cloning and functional expression of the pituitary adenylate cyclase‐activating polypeptide type I receptor. Proc Natl Acad Sci U S A1993;90:6345. CrossRef

221. VilardagaJP, De NeefP, Di PaoloE, et al.Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N‐terminal domain for ligand discrimination. Biochem Biophys Res Commun1995;211:885. CrossRef

222. MiyataA, ArimuraA, DahlRR, et al.Isolation of a novel 38 residue‐hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun1989;164:567. CrossRef

223. JornvallH, CarlquistM, KwaukS, et al.Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP). FEBS Lett1981;123:205. CrossRef

224. MoodyAJ, ThimL, ValverdeI. The isolation and sequencing of human gastric inhibitory peptide (GIP). FEBS Lett1984;172:142. CrossRef

225. VilsbollT, KrarupT, MadsbadS, et al.Both GLP‐1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept2003;114:115. CrossRef

226. LutzMP, SutorSL, AbrahamRT, et al.A role for cholecystokinin‐stimulated protein tyrosine phosphorylation in regulated secretion by the pancreatic acinar cell. J Biol Chem1993;268:11119.

227. MacaraIG, LounsburyKM, RichardsSA, et al.The Ras superfamily of GTPases. FASEB J1996;10:625.

228. DarnellJEJr, KerrIM, StarkGR. Jak‐STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science1994;264:1415. CrossRef

229. KatoT, NishioK. Clinical aspects of epidermal growth factor receptor inhibitors: benefit and risk. Respirology2006;11:693. CrossRef

230. MichelsenKS, ArditiM. Toll‐like receptors and innate immunity in gut homeostasis and pathology. Curr Opin Hematol2007;14:48. CrossRef

231. ShireyKA, LaiW, ScottAJ, et al.The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature2013;497:498. CrossRef

232. CheyWD, CheyWY. Evaluation of secretion and absorptive functions of the gastrointestinal tract. In: YamadaT(ed). Textbook of Gastroenterology, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2003: 3075.

233. DimagnoEP, GoVL. The clinical application of exocrine pancreatic function tests. Dis Mon1976;22:3. CrossRef

234. MillerRE, ChernishSM, RosenakBD, et al.Hypotonic duodenography with glucagon. Radiology1973;108:35. CrossRef

235. SantangeloWC, O'DorisioTM, KimJG, et al.Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport. Ann Intern Med1985;103:363. CrossRef

236. ChristopoulosA. Allosteric binding sites on cell‐surface receptors: novel targets for drug discovery. Nat Rev Drug Discov2002;1:198. CrossRef

237. BordiC, D′AddaT, AzzoniC, et al.Classification of gastric endocrine cells at the light and electron microscopical levels. Microsc Res Tech2000;48:258. CrossRef